Weekly Intelligence · 7 articles
Vet Industry Intel: May 3 – May 9, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Funding & Investment
FDA announcing funding for grants in veterinary innovation
The FDA has announced funding availability for grants dedicated to veterinary innovation, aiming to support advancements in animal health.
FDA · Vet Candy
Regulatory & Policy
FDA clears first drug for both noise aversion and separation anxiety in dogs
The FDA has cleared the first drug approved to treat both noise aversion and separation anxiety in dogs.
FDA · Veterinary Practice News
IV-delivered therapy for canine OA advances toward FDA approval
An intravenous therapy for canine osteoarthritis has advanced toward FDA approval, marking a significant regulatory development in veterinary pharmaceuticals.
FDA · Veterinary Practice News
FDA adds ointment to its emergency use arsenal against screwworm
The FDA has added an ointment to its emergency use authorization arsenal to combat screwworm, as reported by the American Veterinary Medical Association.
FDA · American Veterinary Medical Association
Products & Technology
FDA approves first drug for both noise aversion and separation anxiety in dogs
The FDA has approved the first pharmaceutical drug indicated for treating both noise aversion and separation anxiety in dogs.
FDA · DVM360
Gallant Advances Canine Osteoarthritis IV-Delivered Stem Cell Therapy with Promising Pilot Data and Expanded FDA Conditional Approval Pathway Eligibility
Gallant announced promising pilot data for its IV-delivered stem cell therapy for canine osteoarthritis alongside progress in the FDA conditional approval pathway.
Gallant · FDA · PR Newswire
Industry News
Zoetis (ZTS) Is Down 24.1% After Cutting 2026 Guidance On Softer U.S. Pet Demand – Has The Bull Case Changed?
Zoetis shares fell 24.1% after the company cut its 2026 financial guidance due to softer U.S. pet demand.
Zoetis · Yahoo Finance